BRPI0820915A2 - método para expandir células tronco hematopoéticas usando composto heterocíclico - Google Patents
método para expandir células tronco hematopoéticas usando composto heterocíclicoInfo
- Publication number
- BRPI0820915A2 BRPI0820915A2 BRPI0820915A BRPI0820915A BRPI0820915A2 BR PI0820915 A2 BRPI0820915 A2 BR PI0820915A2 BR PI0820915 A BRPI0820915 A BR PI0820915A BR PI0820915 A BRPI0820915 A BR PI0820915A BR PI0820915 A2 BRPI0820915 A2 BR PI0820915A2
- Authority
- BR
- Brazil
- Prior art keywords
- stem cells
- hematopoietic stem
- heterocyclic compound
- expanding hematopoietic
- expanding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007316276 | 2007-12-06 | ||
| PCT/JP2008/072207 WO2009072635A1 (ja) | 2007-12-06 | 2008-12-06 | ヘテロ環化合物による造血幹細胞の増幅方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0820915A2 true BRPI0820915A2 (pt) | 2017-06-13 |
| BRPI0820915A8 BRPI0820915A8 (pt) | 2017-10-03 |
Family
ID=40717814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0820915A BRPI0820915A8 (pt) | 2007-12-06 | 2008-12-06 | Método para expandir células-tronco hematopoéticas usando composto heterocíclico |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9527828B2 (pt) |
| EP (1) | EP2218716B1 (pt) |
| JP (1) | JP5663169B2 (pt) |
| CN (1) | CN101889007A (pt) |
| AU (1) | AU2008332303B2 (pt) |
| BR (1) | BRPI0820915A8 (pt) |
| CA (1) | CA2708050C (pt) |
| ES (1) | ES2605611T3 (pt) |
| IL (1) | IL206185A0 (pt) |
| WO (1) | WO2009072635A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2439204B1 (en) * | 2009-06-04 | 2017-01-04 | Nissan Chemical Industries, Ltd. | Heterocyclic compound and hematopoietic stem cell amplifier |
| JP5946775B2 (ja) * | 2010-12-01 | 2016-07-06 | 日産化学工業株式会社 | ピラゾール化合物による造血幹細胞の製造方法 |
| US20140227780A1 (en) * | 2011-10-03 | 2014-08-14 | Nissan Chemical Industries, Ltd. | Method for producing megakaryocytes and/or platelets from pluripotent stem cells |
| CN103740644B (zh) * | 2013-03-20 | 2016-08-17 | 深圳爱生再生医学科技有限公司 | 一种基于3d培养体系的扩增造血干细胞的方法 |
| KR20160075676A (ko) * | 2013-10-24 | 2016-06-29 | 오스페달레 산 라파엘 에스.알.엘. | 방법 |
| WO2021224416A1 (en) | 2020-05-06 | 2021-11-11 | Cellectis S.A. | Methods to genetically modify cells for delivery of therapeutic proteins |
| US20230212613A1 (en) | 2020-05-06 | 2023-07-06 | Cellectis S.A. | Methods for targeted insertion of exogenous sequences in cellular genomes |
| US11883436B2 (en) | 2020-08-17 | 2024-01-30 | The Board Of Trustees Of The University Of Illinois | Method of preparing hematopoietic stem and progenitor cells for transplantation |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
| US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
| US5605822A (en) | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
| US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
| US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| US5610056A (en) * | 1994-11-16 | 1997-03-11 | Amgen Inc. | Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells |
| WO1997012978A1 (en) * | 1995-10-05 | 1997-04-10 | G.D. Searle & Co. | NOVEL c-mpl RECEPTOR AGONISTS |
| US6060052A (en) | 1995-10-30 | 2000-05-09 | Systemix, Inc. | Methods for use of Mpl ligands with primitive human hematopoietic stem cells |
| EP1332673B1 (en) | 1998-02-17 | 2012-05-30 | Gamida Cell Ltd. | Method of controlling proliferation and differentiation of stem and progenitor cells |
| US6962698B1 (en) | 1998-02-17 | 2005-11-08 | Gamida Cell Ltd. | Methods of controlling proliferation and differentiation of stem and progenitor cells |
| JP2000023674A (ja) | 1998-07-13 | 2000-01-25 | Kirin Brewery Co Ltd | 分化を抑制するペプチドと造血幹細胞増殖法 |
| JP4453135B2 (ja) | 1999-12-09 | 2010-04-21 | 東ソー株式会社 | 造血細胞の新規増幅剤 |
| ATE391174T1 (de) | 2000-10-20 | 2008-04-15 | Chugai Pharmaceutical Co Ltd | Modifizierter tpo-agonisten antikörper |
| CA2424364A1 (en) | 2000-10-20 | 2003-04-01 | Chugai Seiyaku Kabushiki Kaisha | Degraded tpo agonist antibody |
| EP1465982A4 (en) | 2002-01-25 | 2006-06-07 | Gamida Cell Ltd | PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED |
| JP2004222502A (ja) * | 2003-01-17 | 2004-08-12 | Asahi Kasei Corp | 造血幹細胞増幅法 |
| UA82695C2 (uk) | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
| TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
| JP4651282B2 (ja) * | 2004-01-21 | 2011-03-16 | 田辺三菱製薬株式会社 | 造血幹細胞及び造血前駆細胞の増幅方法 |
| TW200633997A (en) * | 2004-12-08 | 2006-10-01 | Nissan Chemical Ind Ltd | Substituted heterocyclic compounds and thrombopoietin receptor activators |
| TW200633998A (en) * | 2004-12-08 | 2006-10-01 | Nissan Chemical Ind Ltd | Substituted heterocyclic compounds and thrombopoietin receptor activators |
| JP4973192B2 (ja) | 2004-12-14 | 2012-07-11 | 日産化学工業株式会社 | アミド化合物及びトロンボポエチンレセプター活性化剤 |
| US7968542B2 (en) | 2005-07-15 | 2011-06-28 | Nissan Chemical Industries, Ltd. | Thiophene compounds and thrombopoietin receptor activators |
| WO2007108559A1 (ja) * | 2006-03-23 | 2007-09-27 | Kirin Pharma Kabushiki Kaisha | ヒトトロンボポエチン受容体に対するアゴニスト抗体 |
| AU2007259739B2 (en) | 2006-06-14 | 2013-03-07 | Chugai Seiyaku Kabushiki Kaisha | Agents for promoting the growth of hematopoietic stem cells |
-
2008
- 2008-12-06 CA CA2708050A patent/CA2708050C/en not_active Expired - Fee Related
- 2008-12-06 US US12/746,666 patent/US9527828B2/en active Active
- 2008-12-06 BR BRPI0820915A patent/BRPI0820915A8/pt not_active IP Right Cessation
- 2008-12-06 EP EP08858085.7A patent/EP2218716B1/en active Active
- 2008-12-06 WO PCT/JP2008/072207 patent/WO2009072635A1/ja active Application Filing
- 2008-12-06 AU AU2008332303A patent/AU2008332303B2/en not_active Ceased
- 2008-12-06 CN CN2008801196587A patent/CN101889007A/zh active Pending
- 2008-12-06 JP JP2009544761A patent/JP5663169B2/ja active Active
- 2008-12-06 ES ES08858085.7T patent/ES2605611T3/es active Active
-
2010
- 2010-06-03 IL IL206185A patent/IL206185A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9527828B2 (en) | 2016-12-27 |
| EP2218716A4 (en) | 2012-07-25 |
| EP2218716B1 (en) | 2016-11-16 |
| JP5663169B2 (ja) | 2015-02-04 |
| AU2008332303A1 (en) | 2009-06-11 |
| EP2218716A1 (en) | 2010-08-18 |
| BRPI0820915A8 (pt) | 2017-10-03 |
| CA2708050C (en) | 2016-08-16 |
| CA2708050A1 (en) | 2009-06-11 |
| WO2009072635A1 (ja) | 2009-06-11 |
| ES2605611T3 (es) | 2017-03-15 |
| US20100266556A1 (en) | 2010-10-21 |
| CN101889007A (zh) | 2010-11-17 |
| IL206185A0 (en) | 2010-12-30 |
| AU2008332303B2 (en) | 2014-02-13 |
| JPWO2009072635A1 (ja) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0921799A2 (pt) | compostos que expandem células-tronco hematopoéticas | |
| BRPI0917145A2 (pt) | Método para fabricar biocombustíveis | |
| BRPI0810558A2 (pt) | Armazenador para transplante | |
| BRPI1014635A2 (pt) | compostos heterocíclicos e de expansão para células-tronco hematopoiéticas | |
| BRPI0820915A2 (pt) | método para expandir células tronco hematopoéticas usando composto heterocíclico | |
| BRPI0907608A2 (pt) | Formulas dinâmicas para células de planilha | |
| CR10781A (es) | Medios disenado racionalmente para cultivo celular | |
| BRPI0819127A2 (pt) | Método para cimentar. | |
| DK2139892T3 (da) | Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer | |
| DK2069324T3 (da) | Fusioneret aminopyridin som hsp90-inhibitorer | |
| BRPI0822903A2 (pt) | Autoconfiguração para células femto | |
| DK2220070T3 (da) | 2-benzylpyridazinonderivater som Met-kinaseinhibitorer | |
| BRPI0815550A2 (pt) | Método para estabilizar fenilefrina | |
| BRPI0823079A2 (pt) | Unidade flutuante para aramazenamento de gás | |
| BRPI0921950A2 (pt) | suporte para ferramentas | |
| EP2228435A4 (en) | METHOD FOR AMPLIFYING HEMATOPOIETIC STRAIN CELL USING HETEROCYCLIC COMPOUND | |
| EP2228434A4 (en) | Amplification method for hematopoietic stem cells with heterocyclic compound | |
| EP2233561A4 (en) | METHOD FOR AMPLIFYING HEMATOPOIETIC STRAIN CELL USING HETEROCYCLIC COMPOUND | |
| BRPI0814011A2 (pt) | método para preparação de biobutanol | |
| DK2220036T3 (da) | Dioxoanthracensulfonatderivater | |
| FI20075264A0 (fi) | Heterosykliset fenyylikarbamaatit uusina FAAH-inhibiittoreina | |
| BRPI0908497A2 (pt) | métodos e composições para um rendimento aumentado | |
| ES1059333Y (es) | Protector-expositor removible para pilares | |
| BRPI0715339A2 (pt) | Método para proliferar células lak. | |
| BRPI1007891A2 (pt) | métodos para perfurar material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: NISSAN CHEMICAL INDUSTRIES LTD (JP) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |